Target
Kallikrein-1
Ligand
BDBM357157
Substrate
n/a
Meas. Tech.
Kallikrein Assay
Ki
0.780±n/a nM
Citation
 Xu, JAli, AZhou, WGao, YEdmondson, SDMertz, ENeelamkavil, SFLiu, WSun, WShen, DHarper, BZhu, CBara, TLim, YYang, M Factor XIA inhibitors US Patent  US10214512 Publication Date 2/26/2019 
Target
Name:
Kallikrein-1
Synonyms:
KLK1 | KLK1_HUMAN | Kallikrein 1 | Kallikrein-1 | Kidney/pancreas/salivary gland kallikrein | Tissue kallikrein
Type:
Enzyme
Mol. Mass.:
28874.69
Organism:
Homo sapiens (Human)
Description:
P06870
Residue:
262
Sequence:
MWFLVLCLALSLGGTGAAPPIQSRIVGGWECEQHSQPWQAALYHFSTFQCGGILVHRQWVLTAAHCISDNYQLWLGRHNLFDDENTAQFVHVSESFPHPGFNMSLLENHTRQADEDYSHDLMLLRLTEPADTITDAVKVVELPTEEPEVGSTCLASGWGSIEPENFSFPDDLQCVDLKILPNDECKKAHVQKVTDFMLCVGHLEGGKDTCVGDSGGPLMCDGVLQGVTSWGYVPCGTPNKPSVAVRVLSYVKWIEDTIAENS
  
Inhibitor
Name:
BDBM357157
Synonyms:
US10214512, Example 114-c
Type:
Small organic molecule
Emp. Form.:
C29H26ClF2N5O4
Mol. Mass.:
581.998
SMILES:
COC(=O)Nc1ccc2-c3c[nH]c(n3)[C@@H](CCC[C@@H](C)C(=O)Nc2c1)c1ccc(c[n+]1[O-])-c1c(F)ccc(Cl)c1F |r|
Structure:
Search PDB for entries with ligand similarity: